Q3 2023 Holdings
Filed 2023-11-14 | 51 holdings | $3.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $558.9M | 11,584,280 | 18.9% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $414.6M | 10,899,859 | 14.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $250.4M | 5,748,399 | 8.4% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $198.9M | 5,756,268 | 6.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $154.4M | 5,577,863 | 5.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $135.1M | 7,521,024 | 4.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $124.9M | 5,991,479 | 4.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $107.4M | 5,467,063 | 3.6% |
| Xencor Inc(XNCR) | COM | 98401F105 | $106.4M | 5,282,516 | 3.6% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $98.2M | 8,721,636 | 3.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $85.2M | 13,437,473 | 2.9% |
| Springworks Therapeutics Inc | COM | 85205L107 | $80.0M | 3,460,208 | 2.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $53.0M | 5,806,871 | 1.8% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $47.7M | 368,411 | 1.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $45.5M | 1,530,263 | 1.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $36.4M | 5,618,779 | 1.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $35.0M | 4,163,824 | 1.2% |
| Morphic Hldg Inc | COM | 61775R105 | $33.9M | 1,480,190 | 1.1% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $29.8M | 3,851,507 | 1.0% |
| Neumora Therapeutics Inc.(NMRA) | COM ADDED | 640979100 | $29.2M | 2,071,450 | 1.0% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $27.9M | 732,500 | 0.9% |
| Alector Inc(ALEC) | COM | 014442107 | $26.3M | 4,056,548 | 0.9% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $25.7M | 19,209,643 | 0.9% |
| Mersana Therapeutics Inc | COM | 59045L106 | $24.6M | 19,364,688 | 0.8% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $23.5M | 6,117,400 | 0.8% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $21.2M | 8,538,446 | 0.7% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $21.0M | 6,995,861 | 0.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $20.7M | 3,418,068 | 0.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $20.0M | 3,493,194 | 0.7% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $19.1M | 2,982,444 | 0.6% |
| Acelyrin Inc | COM | 00445A100 | $14.3M | 1,402,201 | 0.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $14.2M | 4,488,200 | 0.5% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $12.8M | 5,000,000 | 0.4% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $12.6M | 993,000 | 0.4% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $7.8M | 2,046,867 | 0.3% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $7.7M | 9,195,404 | 0.3% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $7.3M | 700,000 | 0.2% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $6.9M | 6,435,518 | 0.2% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $5.7M | 600,000 | 0.2% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $3.9M | 2,980,016 | 0.1% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $3.6M | 1,157,452 | 0.1% |
| Aligos Therapeutics Inc | COM | 01626L105 | $2.9M | 3,948,360 | 0.1% |
| Hookipa Pharma Inc | COM | 43906K100 | $2.8M | 4,595,024 | 0.1% |
| Aeglea Biotherapeutics Inc(SYRE) | COM NEW ADDED | 00773J202 | $2.4M | 199,996 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $1.7M | 748,900 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $1.3M | 963,333 | 0.0% |
| Revolution Medicines Inc(RVMD)Call | COM | 76155X100 | $866.4K | 31,300 | 0.0% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $616.7K | 66,665 | 0.0% |
| Tempest Therapeutics Inc(OVASUSD) | COM | 87978U108 | $283.7K | 931,000 | 0.0% |
| Caremax Inc | *W EXP 06/08/202 | 14171W111 | $212.0K | 100,000 | 0.0% |